… the brain and serum of patients with Alzheimer disease (AD). We … levels of circulating
plasmalogens and Alzheimer Disease Assessment Scale–Cognitive (ADAS-Cog) scores in patients …

… disease status [3, 44]. Consistently, a ≤ 75% decrease of serum plasmalogens levels in
AD patients … Correspondingly, observations have shown that levels of DHA and DHA-containing …

… the mechanisms by which plasmalogen deficiency leads to Alzheimer’s and/or dementia
and the critical role that 1-O-alkyl-2-acyl glycerol oils can play in patients with those disorders. …

… Plasmalogens (Pls) reportedly decreased in postmortem brain and in the blood of patients
with Alzheimer's disease (AD). Recently we showed that intraperitoneal administration of Pls …

… Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by brain
… and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer’s disease …

… negatively associated with plasmalogen indices, including Alzheimer's Disease Assessment
Scale … plasmalogens with important aspects of Alzheimer's disease (AD) pathophysiology. …

… the levels of Aβ, PCOOH, and PlsEtn in the blood of patients … In both the plasma and RBCs
of patients with AD, the levels of … 18:1 DMA (ie, plasmalogen) levels in patients with AD were …

… elevation of the blood Pls levels. No adverse events were reported. The baseline levels of
plasma ethanolamine plasmalogen and erythrocyte ethanolamine plasmalogen in MCI, AD, …

… To investigate the plausibility of this hypothesis, we first assumed that subjects with low
plasmalogen levels had a significantly shorter life expectancy than subjects with normal levels. …

… Initially, frontal cortex and hippocampus were selected since they are often severely affected
by the disease. These analyses indicated marked changes in PE-plasmalogen and hence, …